See the full story in the original article.
Read the original on Yahoo Finance ↗
Keywords
Open a keyword to see other news on the same topic.
Related news
- What Danaher Stock's AI Lab Push Means For Shareholders
Danaher has announced a collaboration with NVIDIA combining its instruments, automation and software with NVIDIA's AI platforms, along with an AI-powered autonomous lab at Abcam for faster custom antibody development. The article links this push to future demand for more automated, data-rich research, but says it does not fundamentally change near-term risk-reward given China trade frictions and volume-based procurement. Analyst models already assume 8.1% annual revenue growth over three years and margin expansion from 15.9% to 19.3%, so the AI initiatives sit within existing expectations. Consensus sees profit rising from US$4.0b today to about US$6.1b by 2029, with the central target of US$236.32 against a US$214.06 share price. The mid case implies a P/E of about 34.1x on 2029 earnings, versus 37.7x today.
- Healthcare Services Group, Inc. Q3 2026 Earnings Call Summary
- Elevance Health Inc. Q3 2026 Earnings Call Summary
- UnitedHealth Group Incorporated ( UNH ) – What Are Analysts Thinking About This Stock ?
- Medicare Open Enrollment Begins , 2027 Plan Changes Announced
Medicare open enrollment starts Thursday (October 15) and runs until December 7, with changes taking effect January 1, 2027 for more than 70 million enrollees. The Part D out-of-pocket cap rises to $2,400 from $2,100 and the standard deductible increases from $615 to $700, while a temporary Part D premium subsidy ends early at year's end. Social Security benefits will rise 3.6 percent in 2027, about $75 more per month for nearly 72 million recipients. Medicare-negotiated prices take effect for 15 drugs, including Ozempic and Wegovy, and CMS projects the change will reduce prescription drug coverage by $685 million in 2027. President Trump also announced one-time $90 payments in October for more than 20 million Medicare enrollees to help with Part B premiums, costing about $2 billion.
- Medicare Open Enrollment Begins , 2027 Plan Changes Announced
Medicare open enrollment runs October 15 to December 7, letting more than 70 million enrollees choose traditional Medicare, Medicare Advantage or drug plans effective January 1, 2027. Social Security cost-of-living benefits rise 3.6% in 2027, about $75 more per month for nearly 72 million recipients. The Part D out-of-pocket cap rises to $2,400 from $2,100, and the standard deductible increases from $615 to $700, while a temporary Part D premium subsidy ends early; CMS projects only modest increases for most people. Medicare-negotiated prices for 15 drugs, including Ozempic and Wegovy, take effect January 1. Separately, a one-time $90 Part B premium payment in October will help more than 20 million enrollees at a cost of about $2 billion, but excludes roughly 35 million Medicare Advantage enrollees.
Related markets
Latest news
- Meta’s (NASDAQ:META) Q3 2026 sales top estimates, quarterly revenue guidance slightly exceeds expectations
Meta Platforms (NASDAQ: META) reported Q3 revenue of $64.6 billion, up 26.1% year on year and about 2% above estimates. Revenue guidance for the Q4 midpoint is $74.5 billion, 1.2% above analyst expectations. GAAP EPS of $3.83 was 29.9% below consensus, due to a $9.89 billion charge tied to an agreement with 52 attorneys general to resolve teen mental health litigation, with payments of up to about $18.59 billion; excluding it, EPS would have been $7.40. Operating margin fell to 20.1% from 40.1%, and free cash flow was -$2.12 billion. Daily active people reached 3.64 billion, up 100 million year on year.
- A SpaceX-Tesla megamerger could benefit both companies and Elon Musk's personal fortune
SpaceX shares rose 8% and Tesla 3.5% after Elon Musk said each company had formed special committees to discuss a possible combination. At current market values, the merged company would be worth about $3.5 trillion, the largest deal ever, and Musk argues it makes sense because both businesses rely heavily on artificial intelligence. Musk owns 11% of SpaceX and 19% of Tesla, and a change-in-control provision in Tesla's pay plan could treat many performance targets as met in a merger, which would make him richer. Although the shares are very expensive by most measures, most analysts still call them a bargain, and many work for banks hoping to win Musk's business. Democrats have called for investigations into SpaceX's federal contracts and could scuttle plans if they win big in next month's midterm elections.
- Netflix Is Down 38% Since Completing Its 10-For-1 Stock Split. Here's Why the Sell-Off Is Worsening After Its Latest Earnings.
Netflix shares are down 37.9% since the 10-for-1 stock split was completed on November 17, 2025, as of the October 20 close. After its third-quarter 2026 report, the stock fell 5.9% to $64.62 in after-hours trading, which would mark a new two-year low. Revenue rose 11.8% year over year, and operating margin widened from 28.2% to 34.6%, but the company now expects $2.7 billion in full-year ad revenue, down from $3 billion, due to a slower rollout of ad product capabilities. Its 2026 revenue forecast of $51.1 billion sits 0.2% below the prior midpoint, and the article also points to competition from YouTube, a third price increase in under three years, and a valuation of 17 times 2027 earnings. Netflix ended the quarter with $8.19 billion in cash against $12.66 billion in long-term debt.
- Where Will Novo Stock Be in 10 Years?
Novo, a Denmark-based pharmaceutical company, reached an all-time high in 2024 but has since faced clinical and commercial setbacks and lost substantial market value over the past two years. Its diabetes products, including Ozempic and Rybelsus, and its obesity drug Wegovy remain core, but U.S. patents on the active ingredient in these drugs expire in 2032, potentially opening the door to cheaper generics. Near-term catalysts include CagriSema, which could be approved by year-end and combines semaglutide with cagrilintide, though it fell short of the 25% mean weight loss Novo had hoped for. The pipeline also includes amycretin, UBT251, and several oral weight loss candidates. The author sees the pipeline as deep but warns of rising competition from dozens of weight-loss drugs, slower market growth, and possible U.S. drug price negotiations.
- NextEra Energy ( NEE ) Q3 2026 Earnings Call Transcript
NextEra Energy reported third-quarter adjusted earnings per share of $1.24, up 9.7% year over year. Florida Power & Light's net income reached $1.62 billion, versus $1.463 billion a year earlier, while adjusted earnings at NextEra Energy Resources rose 13% to $1.247 billion. The renewables and storage backlog reached 36.7 gigawatts, and FPL raised its large load target to 8 gigawatts by 2032. Shareholders have approved the pending combination with Dominion Energy, with state regulatory reviews expected to conclude in early 2027. Management maintained its 2026 adjusted earnings guidance and is targeting the high end of the range, even though wind generation in Q4 is projected to fall to 90% to 95% of the long-term average due to El Niño.
- Amazon logistics automation offers long-term margin gains, Jefferies says
Jefferies says Amazon's warehouse automation and expanding logistics network could lift retail margins long term by reducing labour dependence. Amazon has deployed over 1 million robots, but only 40% to 45% of its US small-sortable fulfillment centers are highly automated, leaving room for growth. A US$1 hourly wage rise would add about US$1.1 billion to costs, and Amazon has around US$27 billion of visible capex planned for automation and delivery. Jefferies sees third-party parcel delivery as a growth area, with US delivery stations possibly growing from about 575 to 950 by 2030 and early trials showing 20% to 25% savings for shippers. Grocery is harder given US$10 to US$12 delivery cost per order, though the broker sees potential in Amazon's planned Illinois hybrid retail concept expected in 2028.
Get the briefing on Telegram or Zalo
Join the Upside Telegram channel or Zalo group for the Vietnam stocks and gold briefing at 8:00 and 19:00 (Vietnam time) on trading days, plus a weekly wrap on Saturday morning.